MLchartDataset catalogue

17-N-allylamino-17-demethoxygeldanamycin

Term · Oncology and biomedicine · MLC-T-ONC-000016

A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.

Table 1. Record
IdentifierMLC-T-ONC-000016
FieldOncology and biomedicine
Synonyms17-AAG; tanespimycin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000016",
  "term": "17-N-allylamino-17-demethoxygeldanamycin",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.",
  "synonyms": [
    "17-AAG",
    "tanespimycin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/17-n-allylamino-17-demethoxygeldanamycin/"
}

Record 25 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.